ABSTRACT Blood, serum, cerebrospinal fluid, and urine obtained from a patient before and after chelation therapy showed that (1) the ratio of Pb in his cerebrospinal fluid to that in his serum varied from 04 to 0-9 and was independent of serum Pb concentration; (2) the fraction of Pb in his serum fell linearly with decreasing blood Pb concentration and changed from 16% to 0-33% as his blood Pb concentration changed from 116 ,ug/dl (5-6 ,umol/l) to 31 ,ug/dl (15 ,umol/l); and (3) his renal clearance of Pb from serum varied from 5 ml/min to 36 ml/min. This high value was obtained 11 days after chelation and is attributed to large quantities of Sn in his urine promoting the excretion of Pb. Solder was identified in his stool after discovery of radio-opaque material in his bowel. The Pb isotope ratios of the solder were different from those in his urine when he was first admitted, and showed that he had ingested solder when he had returned home on weekend passes.
In the study of the human metabolism of Pb the precise, isotope ratio measuring mass spectrometer has been little used, but is none the less a valuable and versatile instrument. Recent work includes the study of Pb kinetics by oral administration of stable isotopes to healthy subjects,l the identification of the endogenous and exogenous components of Pb in blood through the natural variations in Pb isotope ratios,2 and, by way of the technique of stable isotope dilution, the first accurate measurements of Pb in serum and cerebrospinal fluid.3 We report here an unusual case of Pb poisoning in which we used these mass spectrometric techniques.
Case history
The patient was a 60-year-old white man who complained of the abrupt onset of vertigo, slurred speech, and decreased sensation on the right side of his body. For the past two years his work as a plumber had included soldering and grinding soldered joints on copper pipe to a smooth finish. In January 1979 he left his job because of respiratory complaints attributed to bronchitis. When he developed neurological symptoms he was referred for hour urine coproporphyrin was 1 17 mg/24 h (normal range 100-300 ,ug/24 h). Delta-aminolaevulinic acid screen was "moderately positive," but a repeat sample was negative. The initial computed tomogram (9 May 1979) showed a small arcuate region of low density in the left basal ganglia affecting the junction of the anterior and posterior limbs of the internal capsule. Electroencephalography showed nothing abnormal. Before a lumbar puncture performed as part of his routine evaluation the patient volunteered to be a control in a study of cerebrospinal fluid lead content in patients with amyotrophic lateral sclerosis. The study was approved by the appropriate committee of the University of Texas at Dallas. A repeat computed tomogram (3 July 1979) again showed the small low density region adjacent to the left internal capsule, which was thought to represent an area of lacunar infarction.
Initial cerebrospinal fluid, blood, serum, and urine Pb concentrations were raised. Six weeks later they had increased by 50% ( containing Dowex 1 x8, 200-400 mesh to a height of 16 mm. After draining, the column was washed with three 0-5 ml portions of 6N HCI, followed by three 0-5 ml portions of 8N HF. Sn is retained on the column as the hexafluoride ion and is removed with 2 ml of 2N HNO3. The blank for this procedure is about 1 ng (8 pmol). Small amounts of Cd follow Sn. These are usually not a problem and burn off the filament while Sn is ionising. When the patient was on chelation therapy, however, his urine contained so much Cd that sufficiently large amounts followed Sn so as to almost completely suppress its ionisation. We lost the majority of these runs, even though we put some samples through the ion exchange column twice.
Results
Before chelation, his urinary excretion of Sn and Pb averaged 20 and 230 ,ug/24 h, respectively. The 26Pb/ 207Pb ratio was constant at 1 171 (fig 1) . On the first day of chelation (day 1) he excreted 12 mg Pb (0-58 mmol) and, with the exception of day 5, successively less on the succeeding five days. A small shift in isotope ratio was seen after day 1. His blood Pb initially increased to 123 ,g/dl (5-9 ,umol/l) but fell to 45 ,ug/dl (22 ,umol/l) by day 5. On days 7 and 8, the weekend, the patient went home. The Pb content of his urine continued to decrease, but that of Sn increased. His isotope ratio attained the baseline value on day 7 but increased on day 8. Blood drawn the following morning, before resumption of chelation therapy, showed that the isotope ratio of the Pb in his body was rapidly changing. Except for a decline on day 10 the ratio in his urine increased to a maximum of 1-192 on day 12. It then declined until day 14, the first day of the following weekend when the patient again went home. On day 15, the Sunday, the isotope ratio of his urine increased and the following morning his blood Pb stood at 70 ,ug/dl (3 4 Amol/l). On 1) , when administration of EDTA started, represent those of the skeletal pool. The substance EDTA is rapidly cleared from plasma, so that the 12-hour urine samples collected when administration of EDTA had ceased tend to have lower isotope ratios, because they contain some Pb with the baseline isotope ratio, which began to enter plasma from the erythrocytes and the soft tissues. Samples taken more than 12 hours after administration of EDTA, such as blood on day 7 and urine on day 9, have the baseline isotope ratio and are samplings of soft tissue Pb in transit to tlhe skeleton. Once the patient began ingesting solder, the EDTA bound with both skeletal Pb and the Pb entering the plasma from his gut; while EDTA was not being administered, Pb from solder continued to enter his plasma and together with soft tissue Pb replaced the Pb removed from his skeleton. The result was that by the end of the treatment the patient had replaced Pb of one isotope ratio in his skeletal pool with Pb of another isotope ratio, which thereafter dominated the isotope ratio of his blood. The blood sample of day 20 is conspicuous for having an isotope ratio greater than that of urine. Since this sample was taken 12 hours after administration of EDTA, this blood Pb is interpreted to be newly absorbed Pb from solder mixed with some soft tissue Pb.
One of the patient's premolars contained 56 ppm Pb with an isotope ratio of 1 207, which is probably representative of the Pb in his compact bone, as the half life of Pb in that region of his skeleton is of the order of tens of years. The constancy of the isotope ratio (1 171) of Pb in his urine during the first week of chelation indicates that EDTA did not chelate a significant fraction of the Pb bound in compact bone. This observation, taken with the decreasing amounts of Pb in his urine, suggests that the chelatable pool is of limited size and near constant in isotope ratio, the same conclusion as reached by Hammond.6 Interestingly the ratio in his tooth, which reflects the Pb to which he was exposed 40 to 50 years ago, is somewhat greater than that found in the blood of current Dallas residents. 
